The Joint Committee on Health Care Financing will host a legislative hearing at noon on Wednesday, March 11th in Room B-1. As we discussed here, this bill will prevent the use of health data for marketing purposes. Pharmaceutical companies use data they bought from Health Information Organizations (HIO’s) to directly target a physician to switch from drug A to drug B. This practice increases costs to the health care system, and can endanger patient safety. The Massachusetts Prescription Reform Coalition will be providing testimony in support of SB 17, SB 19, HB 109, and HB110.
Follow us as we tweet this event at twitter.com/hcfa!
Georgia Maheras
